These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 19578004
1. Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Fernandez-Fresnedo G, Segarra A, González E, Alexandru S, Delgado R, Ramos N, Egido J, Praga M, Trabajo de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN). Clin J Am Soc Nephrol; 2009 Aug; 4(8):1317-23. PubMed ID: 19578004 [Abstract] [Full Text] [Related]
2. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study. Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Barreca A, Fenoglio R, Baldovino S, Menegatti E. Am J Nephrol; 2017 Aug; 46(2):108-113. PubMed ID: 28700988 [Abstract] [Full Text] [Related]
3. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab. Marasà M, Cravedi P, Ruggiero B, Ruggenenti P. BMJ Case Rep; 2014 Aug 25; 2014():. PubMed ID: 25155494 [Abstract] [Full Text] [Related]
4. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report. Kolonko A, Piecha G, Więcek A. Transplant Proc; 2016 Nov 25; 48(9):3092-3094. PubMed ID: 27932154 [Abstract] [Full Text] [Related]
5. Rituximab treatment for adult patients with focal segmental glomerulosclerosis. Ochi A, Takei T, Nakayama K, Iwasaki C, Kamei D, Tsuruta Y, Shimizu A, Shiohira S, Moriyama T, Itabashi M, Mochizuki T, Uchida K, Tsuchiya K, Hattori M, Nitta K. Intern Med; 2012 Nov 25; 51(7):759-62. PubMed ID: 22466834 [Abstract] [Full Text] [Related]
6. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Suri M, Tran K, Sharma AP, Filler G, Grimmer J. Int Urol Nephrol; 2008 Nov 25; 40(3):807-10. PubMed ID: 18491215 [Abstract] [Full Text] [Related]
7. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Yabu JM, Ho B, Scandling JD, Vincenti F. Am J Transplant; 2008 Jan 25; 8(1):222-7. PubMed ID: 17979998 [Abstract] [Full Text] [Related]
8. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Kaito H, Kamei K, Kikuchi E, Ogura M, Matsuoka K, Nagata M, Iijima K, Ito S. Pediatr Nephrol; 2010 May 25; 25(5):957-9. PubMed ID: 20033219 [Abstract] [Full Text] [Related]
9. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children. Han KH, Kim SH. Biomed Res Int; 2016 May 25; 2016():3053706. PubMed ID: 27195285 [Abstract] [Full Text] [Related]
10. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis. Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D. Expert Opin Investig Drugs; 2018 Nov 25; 27(11):839-879. PubMed ID: 30360670 [Abstract] [Full Text] [Related]
11. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA. Transpl Int; 2007 Jun 25; 20(6):558-62. PubMed ID: 17433091 [Abstract] [Full Text] [Related]
12. Rituximab for refractory focal segmental glomerulosclerosis. Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K. Pediatr Nephrol; 2008 Mar 25; 23(3):481-5. PubMed ID: 17973121 [Abstract] [Full Text] [Related]
13. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Kamar N, Faguer S, Esposito L, Guitard J, Nogier MB, Durand D, Rostaing L. Clin Nephrol; 2007 Apr 25; 67(4):250-4. PubMed ID: 17474562 [Abstract] [Full Text] [Related]
14. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature. Kisner T, Burst V, Teschner S, Benzing T, Kurschat CE. Nephron Clin Pract; 2012 Apr 25; 120(2):c79-85. PubMed ID: 22286071 [Abstract] [Full Text] [Related]
15. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis. Ino A, Kaori S, Takei T, Nitta K. CEN Case Rep; 2020 Aug 25; 9(3):195-199. PubMed ID: 31997159 [Abstract] [Full Text] [Related]
16. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis. Kumar J, Shatat IF, Skversky AL, Woroniecki RP, Del Rio M, Perelstein EM, Johnson VL, Mahesh S. Pediatr Nephrol; 2013 Feb 25; 28(2):333-8. PubMed ID: 23052653 [Abstract] [Full Text] [Related]
17. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency]. Hyla-Klekot L, Grenda R, Pulcer B. Pol Merkur Lekarski; 2008 Dec 25; 25(150):519-22. PubMed ID: 19205386 [Abstract] [Full Text] [Related]
18. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis. Rodríguez-Ferrero M, Ampuero J, Anaya F. Transplant Proc; 2009 Dec 25; 41(6):2406-8. PubMed ID: 19715934 [Abstract] [Full Text] [Related]
19. Rituximab in treatment of collapsing FSGS-A case series. Girimaji N, Bharati J, Nada R, Rathi M, Kohli HS, Ramachandran R. Nephrology (Carlton); 2021 Feb 25; 26(2):134-141. PubMed ID: 32662534 [Abstract] [Full Text] [Related]
20. Treatment of steroid-resistant focal segmental glomerulosclerosis with rituximab: A case report and review of literature. Varwani MH, Sokwala A. Saudi J Kidney Dis Transpl; 2017 Feb 25; 28(5):1175-1179. PubMed ID: 28937082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]